NASDAQ:CERN - Cerner Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $53.25 +0.27 (+0.51 %) (As of 01/23/2019 11:19 AM ET)Previous Close$52.98Today's Range$52.96 - $53.6052-Week Range$48.78 - $69.90Volume54,500 shsAverage Volume1.65 million shsMarket Capitalization$17.55 billionP/E Ratio24.23Dividend YieldN/ABeta0.98 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform that enables organizations to aggregate, transform, and reconcile data across the continuum of care, as well as EHR agnostic platform, CareAware that facilitates connectivity of health care devices to EHRs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental, connectivity, population health, and care coordination solutions; and various complementary services, including support, hosting, managed, implementation, and strategic consulting services. Further, it provides various services, such as implementation and training, remote hosting, operational management, revenue cycle, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third party administrator services; and complementary hardware and devices for third parties. It serves integrated delivery networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmaceutical manufacturers, employers, governments, and public health organizations. It has a strategic collaboration with Christiana Care Health System to provide a weight loss surgery program. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri. Receive CERN News and Ratings via Email Sign-up to receive the latest news and ratings for CERN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Computer integrated systems design Sub-IndustryHealth Care Technology SectorMedical Current SymbolNASDAQ:CERN Previous Symbol CUSIP15678210 Webwww.cerner.com Phone816-221-1024Debt Debt-to-Equity Ratio0.09 Current Ratio2.63 Quick Ratio2.60Price-To-Earnings Trailing P/E Ratio24.23 Forward P/E Ratio23.99 P/E Growth1.61 Sales & Book Value Annual Sales$5.14 billion Price / Sales3.41 Cash Flow$3.9241 per share Price / Cash Flow13.57 Book Value$14.40 per share Price / Book3.70Profitability EPS (Most Recent Fiscal Year)$2.20 Net Income$866.97 million Net Margins15.72% Return on Equity14.73% Return on Assets11.00%Miscellaneous Employees26,000 Outstanding Shares329,490,000Market Cap$17.55 billion OptionableOptionable Cerner (NASDAQ:CERN) Frequently Asked Questions What is Cerner's stock symbol? Cerner trades on the NASDAQ under the ticker symbol "CERN." How will Cerner's stock buyback program work? Cerner announced that its Board of Directors has initiated a stock repurchase plan on Sunday, June 4th 2017, which allows the company to repurchase $500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 2.3% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's management believes its shares are undervalued. How were Cerner's earnings last quarter? Cerner Co. (NASDAQ:CERN) issued its earnings results on Thursday, October, 25th. The company reported $0.57 EPS for the quarter, missing analysts' consensus estimates of $0.58 by $0.01. The firm had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.36 billion. Cerner had a return on equity of 14.73% and a net margin of 15.72%. View Cerner's Earnings History. When is Cerner's next earnings date? Cerner is scheduled to release their next quarterly earnings announcement on Tuesday, February 5th 2019. View Earnings Estimates for Cerner. How can I listen to Cerner's earnings call? Cerner will be holding an earnings conference call on Tuesday, February 5th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 6785097542. What guidance has Cerner issued on next quarter's earnings? Cerner updated its FY 2018 earnings guidance on Thursday, October, 25th. The company provided earnings per share guidance of $2.46-2.46 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.50. The company issued revenue guidance of $5.396-5.396 billion, compared to the consensus revenue estimate of $5.41 billion.Cerner also updated its Q4 2018 guidance to $0.62-0.64 EPS. What price target have analysts set for CERN? 17 Wall Street analysts have issued 1 year price targets for Cerner's shares. Their predictions range from $54.00 to $76.00. On average, they expect Cerner's share price to reach $69.31 in the next twelve months. This suggests a possible upside of 30.0% from the stock's current price. View Analyst Price Targets for Cerner. What is the consensus analysts' recommendation for Cerner? 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cerner in the last year. There are currently 6 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cerner. What are Wall Street analysts saying about Cerner stock? Here are some recent quotes from research analysts about Cerner stock: 1. According to Zacks Investment Research, "Cerner underperformed the industry in a year's time. Additionally, the company’s key Licensed Software and Subscriptions revenue segments have been witnessing some sluggishness in recent times. In fact, management expects low Licensed Software bookings to affect total bookings in the quarters to come. Contraction in gross and operating margins adds to the woes. High long-term debt and competition in the global MedTech space raise concern. On the brighter side, Cerner continues to gain from its Population Health, Revenue Cycle and ITWorks platforms. Solid year-over-year bookings growth is a positive. Gains in Professional and Managed Services units buoy optimism. Management is optimistic about the alliance with Lumeris, signed earlier this year. Continued activity with the Department of Veterans Affairs encourages. A strong fourth-quarter and full-year outlook is heartening." (12/31/2018) 2. Cantor Fitzgerald analysts commented, "Our rating remains Overweight and our PT remains $80. Although some amount of investor skepticism regarding the company’s growth outlook continues to temper valuation levels, we do not share those concerns. Our long-term DCF model assumptions are mostly conservative, with high single-digit revenue growth and modest margin expansion. Capital spending should moderate in 2019. We think the shares offer a compelling risk/reward trade off (including the potential impact from the VA contract). Valuation Summary Cerner shares trade at a 25% discount to our DCF-based price target of $80 (including the VA contract)." (9/12/2018) Has Cerner been receiving favorable news coverage? Press coverage about CERN stock has been trending somewhat positive this week, according to InfoTrie. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cerner earned a media sentiment score of 1.4 on InfoTrie's scale. They also gave media stories about the company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the near term. Who are some of Cerner's key competitors? Some companies that are related to Cerner include Altaba (AABA), Godaddy (GDDY), Jack Henry & Associates (JKHY), Open Text (OTEX), Leidos (LDOS), Caci International (CACI), Verint Systems (VRNT), Science Applications International (SAIC), Scientific Games (SGMS), Allscripts Healthcare Solutions (MDRX), NetScout Systems (NTCT), Ebix (EBIX), Nextgen Healthcare (NXGN), Sykes Enterprises (SYKE) and Unisys (UIS). Who are Cerner's key executives? Cerner's management team includes the folowing people: Mr. Clifford W. Illig, Co-Founder & Vice Chairman (Age 68)Mr. Marc G. Naughton, Exec. VP & CFO (Age 64)Mr. Michael R. Nill, Exec. VP & COO (Age 54)Mr. Jeffrey A. Townsend, Exec. VP & Chief of Innovation (Age 55)Mr. David Brent Shafer, Chairman & CEO (Age 62) Who are Cerner's major shareholders? Cerner's stock is owned by many different of institutional and retail investors. Top institutional shareholders include LGT Capital Partners LTD. (0.34%), Douglas Lane & Associates LLC (0.28%), Davis R M Inc. (0.19%), Bank of Montreal Can (0.16%), Alta Capital Management LLC (0.10%) and Reinhart Partners Inc. (0.09%). Company insiders that own Cerner stock include Clifford W Illig, David Brent Shafer, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Neal L Patterson, Randy D Sims, William D Zollars and Zane M Burke. View Institutional Ownership Trends for Cerner. Which institutional investors are selling Cerner stock? CERN stock was sold by a variety of institutional investors in the last quarter, including Douglas Lane & Associates LLC, Davis R M Inc., Cullinan Associates Inc., DNB Asset Management AS, Gulf International Bank UK Ltd, Arcadia Investment Management Corp MI, Oakbrook Investments LLC and Webster Bank N. A.. Company insiders that have sold Cerner company stock in the last year include Clifford W Illig, David Brent Shafer, Denis A Cortese, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Michael R Battaglioli, William D Zollars and Zane M Burke. View Insider Buying and Selling for Cerner. Which institutional investors are buying Cerner stock? CERN stock was bought by a variety of institutional investors in the last quarter, including Reinhart Partners Inc., Bank of Montreal Can, LGT Capital Partners LTD., Beacon Financial Group, BTIM Corp., Bell Asset Management Ltd, TrimTabs Asset Management LLC and Virtu Financial LLC. View Insider Buying and Selling for Cerner. How do I buy shares of Cerner? Shares of CERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Cerner's stock price today? One share of CERN stock can currently be purchased for approximately $53.3050. How big of a company is Cerner? Cerner has a market capitalization of $17.56 billion and generates $5.14 billion in revenue each year. The company earns $866.97 million in net income (profit) each year or $2.20 on an earnings per share basis. Cerner employs 26,000 workers across the globe. What is Cerner's official website? The official website for Cerner is http://www.cerner.com. How can I contact Cerner? Cerner's mailing address is 2800 ROCKCREEK PKWY W0162, NORTH KANSAS CITY MO, 64117. The company can be reached via phone at 816-221-1024 or via email at [email protected] MarketBeat Community Rating for Cerner (NASDAQ CERN)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 858 (Vote Outperform)Underperform Votes: 533 (Vote Underperform)Total Votes: 1,391MarketBeat's community ratings are surveys of what our community members think about Cerner and other stocks. Vote "Outperform" if you believe CERN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/23/2019 by MarketBeat.com StaffFeatured Article: What type of investment options does a Roth IRA provide?